hesperetin has been researched along with Demyelinating Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baradaran, S; Ghasemi-Kasman, M; Moghaddam, AH | 1 |
| Baradaran, S; Ghasemi-Kasman, M; Hajizadeh Moghaddam, A | 1 |
2 other study(ies) available for hesperetin and Demyelinating Diseases
| Article | Year |
|---|---|
Nano-hesperetin enhances the functional recovery and endogenous remyelination of the optic pathway in focal demyelination model.
Topics: Animals; Demyelinating Diseases; Disease Models, Animal; Evoked Potentials, Visual; Hesperidin; Male; Optic Chiasm; Rats; Rats, Wistar; Recovery of Function; Remyelination; Visual Cortex; Visual Pathways | 2020 |
Hesperetin reduces myelin damage and ameliorates glial activation in lysolecithin-induced focal demyelination model of rat optic chiasm.
Topics: Animals; Antioxidants; Citrus; Demyelinating Diseases; Disease Models, Animal; Evoked Potentials, Visual; Hesperidin; Lysophosphatidylcholines; Male; Multiple Sclerosis; Myelin Sheath; Neuroglia; Optic Chiasm; Rats; Rats, Wistar | 2018 |